Immune, Gut & LongevityAn evidence-first ranking of the peptides studied for rheumatoid and autoimmune arthritis — thymosin alpha-1, BPC-157, ARA-290 and KPV — separating real human data from preclinical promise, and flagging the immune-flare risk in a joint-destroying disease.
Immune, Gut & Longevity12 MIN READ
Immune, Gut & LongevityAn evidence-first ranking of the peptides studied for inflammaging and chronic low-grade inflammation of aging — thymosin alpha-1, ARA-290, thymalin, BPC-157 and KPV — separating real human trials from preclinical promise, and flagging the bidirectional immune risk.
Immune, Gut & Longevity13 MIN READ
Immune, Gut & LongevityAn evidence-first ranking of the peptides studied for immune support and function — thymosin alpha-1, thymalin, LL-37 and thymogen — separating a genuine Grade A human-trial candidate from single-school and preclinical claims.
Immune, Gut & Longevity12 MIN READ
Immune, Gut & LongevityAn evidence-first ranking of the peptides studied for autoimmune modulation — larazotide, thymosin alpha-1, ARA-290 and KPV — separating real human trials from preclinical promise, and flagging the bidirectional immune risk.
Immune, Gut & Longevity12 MIN READ
Peptide EncyclopediaA clinical monograph on LL-37 — the only human cathelicidin antimicrobial peptide. Small topical wound-healing RCTs (grade B), strong preclinical mechanism, and a sharply double-edged immune profile.
Peptide Encyclopedia12 MIN READ